Phase II study to evaluate the safety and efficacy of intravenous palonosetron (PAL) in primary malignant glioma (MG) patients receiving standard radiotherapy (RT) and concomitant temozolomide (TMZ)

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Affronti, ML; Woodring, S; Allen, K; Kirkpatrick, J; Peters, KB; II, HJE; McSherry, F; Healy, PN; Desjardins, A; Vredenburgh, JJ; Friedman, HS

Published Date

  • October 2016

Published In

Volume / Issue

  • 24 / 10

Start / End Page

  • 4365 - 4375

Electronic International Standard Serial Number (EISSN)

  • 1433-7339

International Standard Serial Number (ISSN)

  • 0941-4355

Digital Object Identifier (DOI)

  • 10.1007/s00520-016-3276-1